Previous studies in mdx mice have also shown amelioration of DMD phenotypes after targeting the HMGB1 receptors TLR4 and advanced glycosylation end product-specific receptor (RAGE) (Giordano et al., 2015; Sagheddu et al., 2018). This evidence concerns the gene TLR4 and Duchenne muscular dystrophy.